Platinum Investment Management LTD Adc Therapeutics Sa Transaction History
Platinum Investment Management LTD
- $2.16 Billion
- Q3 2024
A detailed history of Platinum Investment Management LTD transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Platinum Investment Management LTD holds 1,444,516 shares of ADCT stock, worth $2.93 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
1,444,516
Previous 1,296,153
11.45%
Holding current value
$2.93 Million
Previous $4.1 Million
11.11%
% of portfolio
0.21%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding ADCT
# of Institutions
80Shares Held
55.1MCall Options Held
82.7KPut Options Held
31.5K-
Redmile Group, LLC San Francisco, CA15.7MShares$31.8 Million3.23% of portfolio
-
Prosight Management, LP Dallas, TX9.64MShares$19.6 Million8.15% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.53MShares$9.2 Million0.34% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$7.22 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$6.17 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $158M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...